Shavit Capital

Shavit Capital is an investment firm that specializes in late-stage investments in Israeli and Israeli-related companies

Shavit Capital has over $400 million under management across five separate private equity funds Shavit Capital was founded in 2008 and the fifth fund was raised in 2019 The Funds invest in Israeli companies with proven technologies, products, markets and strong management teams The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a company that trades on the Tel Aviv Stock Exchange

Shavit Capital also invests in other late-stage opportunities, especially through PIPEs (Private Investment in Public Equites) of Israeli publicly-traded companies

• Company News Novachem offers metered-dosing inhaler to Australian patients December 21, 2022 AI Will Drive The Evolution Of Human Creativity December 13, 2022 Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Dia January 31, 2023 PolyPid Provides Positive Regulatory Update for D-PLEX₁₀₀ for the Preve January 24, 2023 LEVI STRAUSS & CO
• TAPS FASHION FOR GOOD TO START HOME-COMPOSTABLE PACKAGING January 16, 2023 PolyPid Announces Publication in the American Journal of Surgery of Phase 2 C January 3, 2023 Chemomab Reports Top-Line Results from CM-101 Phase 2a Liver Fibrosis Biomark January 3, 2023 Lightricks expands to image editing for desktop December 22, 2022 Tulsa ER & Hospital Adopts Trailblazing MeMed BV® Test December 22, 2022 Chemomab Reports Independent Drug Monitoring Committee Safety Review of CM-10 December 21, 2022 Novachem offers metered-dosing inhaler to Australian patients December 21, 2022 AI Will Drive The Evolution Of Human Creativity December 13, 2022 Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Dia January 31, 2023 PolyPid Provides Positive Regulatory Update for D-PLEX₁₀₀ for the Preve January 24, 2023